EULEXIN SALES RUNNING AT $ 3 MIL. PER MONTH, SCHERING-PLOUGH's GARNIER REPORTS; PROVENTIL TO TOP $ 200 MIL. IN 1989, GENERIC PROTECTION LIKELY

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".